Compare IKT & ONEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IKT | ONEW |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto & Home Supply Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.5M | 211.7M |
| IPO Year | 2020 | 2019 |
| Metric | IKT | ONEW |
|---|---|---|
| Price | $2.41 | $11.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $5.00 | ★ $16.50 |
| AVG Volume (30 Days) | ★ 373.8K | 104.5K |
| Earning Date | 03-26-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.76 | N/A |
| EPS | N/A | ★ 2.77 |
| Revenue | N/A | ★ $1,872,334,000.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | N/A | $3.14 |
| P/E Ratio | ★ N/A | $4.22 |
| Revenue Growth | N/A | ★ 5.62 |
| 52 Week Low | $1.33 | $8.12 |
| 52 Week High | $2.61 | $17.35 |
| Indicator | IKT | ONEW |
|---|---|---|
| Relative Strength Index (RSI) | 50.59 | 40.73 |
| Support Level | $2.29 | $10.19 |
| Resistance Level | $2.53 | $12.11 |
| Average True Range (ATR) | 0.11 | 0.70 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 36.76 | 2.13 |
Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosine kinases, including platelet derived growth factor receptors and a stem cell factor receptor, known as c-Kit, has been implicated. Its product candidate is IKT-001, a prodrug of imatinib mesylate (imatinib), for PAH which is an orphan indication. The company has developed its own portfolio of protein kinase inhibitors to treat bacterial and viral infections, including viral infections in the brain. It has one reporting segment, which is the business of developing protein kinase inhibitor therapeutics.
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.